M

Medicinova

D
MNOV
USD
0.08
(5%)
Market Closed
254.000
Volume
-0.23
EPS
-
Div Yield
-10.500000
P/E
82,397,693.28
Market Cap
Today
5.0000%
1 Week
-13.402%
1 Month
42.373%
6 Months
19.149%
12 Months
-21.127%
Year To Date
12.000%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
MRNA
MRNA
-1.79
(-2.5637%)
USD
N
NVAX
-0.01
(-0.0796%)
USD
A
AEMD
0.0419
(11.7697%)
USD
V
VXRT
-0.0008
(-0.0886%)
USD
I
INO
-0.09
(-1.3294%)
USD
B
BNTX
-3
(-2.5972%)
USD
C
CRVS
0.07
(1.275%)
USD
O
ORTX
(%)
USD
S
SRNE
(%)
USD
V
VXRT
-0.0008
(-0.0886%)
USD
A
ARCT
0.49
(2.3833%)
USD

Title:
Medicinova

Sector:
Healthcare
Industry:
Biotechnology
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
Do you need help or have a question?
Contact Us